Appointment Notice - Novo Nordisk Canada Inc.

MISSISSAUGA, ON, July 24, 2015/CNW/ - Mr. Jakob Riis, Executive Vice President, China, Pacific & Marketing, Novo Nordisk A/S, is pleased to announce the appointment of Mr. Brian Hilberdink to the role of President, Novo Nordisk Canada Inc.

Mr. Hilberdink is an accomplished executive with 20 years of global and domestic experience developing and executing Novo Nordisk's commercial strategy. He previously held the position of Vice President, Diabetes Marketing and Market Access, Novo Nordisk Canada. Prior to this role, Brian was Corporate Vice President, Global Marketing, Novo Nordisk A/S, and led the commercialization of the company's future insulin portfolio, from phase 2 clinical development until the first launches in Europe and Japan. He also has experience working in the U.S. where, as Director, Brand Management, he led multiple brand teams during a period of significant growth for Novo Nordisk U.S.

"I'm truly honoured to be part of an organization that has played a central role in helping to defeat diabetes and other serious chronic conditions, such as hemophilia, growth disorders and obesity," said Brian Hilberdink, President, Novo Nordisk Canada. "Moving forward, I am excited about the opportunity to have an even greater impact in Canada through the development of strong partnerships and the offering of new products and services to best support patients, their families and healthcare professionals."

About Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: hemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 39,000 people in 75 countries and markets its products in more than 180 countries. For more information, visit novonordisk.com,Facebook, Twitter, LinkedIn, YouTube

SOURCE Novo Nordisk Canada Inc.